Healpros Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 1.00 M
as on 04-12-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.99 M
as on 04-12-2024
- Revenue 37.53%
(FY 2022)
- Profit 26.23%
(FY 2022)
- Ebitda 186.68%
(FY 2022)
- Net Worth 5.73%
(FY 2022)
- Total Assets 92.52%
(FY 2022)
About Healpros Biomedicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.99 M.
Hitesh Kumbhare, Jyoti Kumbhare, Santosh Telang, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110MP2019PTC048809
- Company No.
048809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Healpros Biomedicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Kumbhare  | Managing Director | 06-Jun-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Kumbhare | Director | 06-Jun-2019 | Current |
| Santosh Telang | Director | 29-Jan-2022 | Current |
| Pritam Nagar | Director | 29-Jan-2022 | Current |
Financial Performance of Healpros Biomedicals.
Healpros Biomedicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.53% increase. The company also saw a substantial improvement in profitability, with a 26.23% increase in profit. The company's net worth moved up by a moderate rise of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healpros Biomedicals?
In 2022, Healpros Biomedicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 29 Jan 2021 | ₹4.99 M | Open |
How Many Employees Work at Healpros Biomedicals?
Unlock and access historical data on people associated with Healpros Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healpros Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healpros Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
